Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Low HDL cholesterol is linked to higher cardiovascular risk, but on its own it does not mean a heart attack is coming, since overall risk depends on LDL levels, blood pressure, blood sugar, smoking, weight, family history, and inflammation. Many people with low HDL never have a cardiac event, while others with normal HDL still do, so the number is one clue rather than a verdict. There are several important factors, including which causes of low HDL are treatable through diet, exercise, and medication, explained in the complete answer below. Because chest pressure, breathlessness, jaw or arm discomfort, and unusual fatigue can signal heart trouble that a lab value alone cannot predict, it helps to look at your full picture of symptoms and risk factors. Take a free, instant, online symptom check to see what your symptoms may mean and to get clear guidance on whether to monitor at home, book a routine visit, or seek urgent care.
Last reviewed for medical accuracy: 09/13/2026
Does Low HDL Cholesterol Mean I’m Going to Have a Heart Attack?
Understanding your cholesterol numbers can feel overwhelming. You may have heard that HDL cholesterol is the “good” kind, and that having low levels raises your risk of heart disease. While it’s true that HDL cholesterol plays an important role in cardiovascular health, low HDL alone does not guarantee you will have a heart attack. Here’s what you need to know in clear, straightforward terms.
What Is HDL Cholesterol?
HDL stands for high-density lipoprotein. Lipoproteins are particles that carry cholesterol and other fats through your bloodstream. HDL cholesterol:
In general, higher HDL levels are associated with lower rates of heart disease. But HDL is just one piece of a larger puzzle.
How Low HDL Affects Heart Attack Risk
Multiple large studies, including those summarized by the American Heart Association and Mayo Clinic, have shown that people with HDL levels below 40 mg/dL (in men) or 50 mg/dL (in women) face a higher risk of cardiovascular events compared with those who have higher HDL. However:
In other words, low HDL doesn’t seal your fate. It signals the need for a closer look at your overall heart health.
Your Complete Risk Profile
Cardiologists assess a range of factors to estimate your risk of heart attack over the next 10 years. These include:
A low HDL reading is a red flag—especially if other risk factors are present—but it’s not an automatic predictor of a heart attack.
Lifestyle Changes to Improve HDL and Heart Health
The good news? You can positively influence many risk factors with lifestyle adjustments. Even modest improvements often yield measurable benefits.
Move More
Adopt a Heart-Healthy Diet
Lose Excess Weight
Quit Smoking
Limit Alcohol
Manage Stress
Medications and When They’re Used
Currently, most cholesterol-lowering drugs focus on reducing LDL, not raising HDL. Statins, ezetimibe, and PCSK9 inhibitors are the mainstays for preventing heart attacks in high-risk individuals. In some cases, doctors may add niacin or fibrates to target low HDL or high triglycerides—but only if lifestyle changes aren’t enough and the overall risk justifies it.
Monitoring and Follow-Up
Work with your healthcare provider to:
When to Check Symptoms Online
If you notice new or worrying symptoms—chest discomfort, unexplained shortness of breath, dizziness—it’s wise to do a quick, reliable assessment before deciding on next steps. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Putting It All Together
If you’re concerned about your cholesterol numbers or experiencing any troubling symptoms, don’t delay. Speak to a doctor for personalized advice—and if you encounter serious or life-threatening issues, seek medical attention right away.
(References)
* Sartore G, Seraglia R, Burlina S, Bolis A, Marin R, Manzato E, Ragazzi E, Traldi P, Lapolla A. High-density lipoprotein oxidation in type 2 diabetic patients and young patients with premature myocardial infarction. Nutr Metab Cardiovasc Dis. 2015 Apr;25(4):418-25. doi: 10.1016/j.numecd.2014.12.004. Epub 2014 Dec 19. PMID: 25636381.
* Egeland GM, Igland J, Vollset SE, Sulo G, Eide GE, Tell GS. High population attributable fractions of myocardial infarction associated with waist-hip ratio. Obesity (Silver Spring). 2016 May;24(5):1162-9. doi: 10.1002/oby.21452. Epub 2016 Mar 31. PMID: 27030172; PMCID: PMC5071698.
* Lee CH, Woo JS, Park CB, Cho JM, Ahn YK, Kim CJ, Jeong MH, Kim W, other Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Roles of High-Density Lipoprotein Cholesterol in Patients With Acute Myocardial Infarction. Medicine (Baltimore). 2016 May;95(18):e3319. doi: 10.1097/MD.0000000000003319. PMID: 27149442; PMCID: PMC4863759.
* Park JS, Cha KS, Lee HW, Oh JH, Choi JH, Lee HC, Hong TJ, Jeong MH, Chae SC, Kim YJ. Predictive and protective role of high-density lipoprotein cholesterol in acute myocardial infarction. Cardiol J. 2019;26(2):176-185. doi: 10.5603/CJ.a2018.0020. Epub 2018 Mar 7. PMID: 29512093; PMCID: PMC8086654.
* Winter MP, Wiesbauer F, Blessberger H, Pavo N, Sulzgruber P, Huber K, Wojta J, Distelmaier K, Lang IM, Goliasch G. Lipid profile and long-term outcome in premature myocardial infarction. Eur J Clin Invest. 2018 Oct;48(10):e13008. doi: 10.1111/eci.13008. Epub 2018 Aug 13. PMID: 30062727.
* Ishibashi T, Kaneko H, Matsuoka S, Suzuki Y, Ueno K, Ohno R, Okada A, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Node K, Yasunaga H, Komuro I. HDL cholesterol and clinical outcomes in diabetes mellitus. Eur J Prev Cardiol. 2023 Jun 1;30(8):646-653. doi: 10.1093/eurjpc/zwad029. PMID: 36738171.
* Deets A, Joshi PH, Chandra A, Singh K, Khera A, Virani SS, Ballantyne CM, Otvos JD, Dullaart RPF, Gruppen EG, Connelly MA, Ayers C, Navar AM, Pandey A, Wilkins JT, Rohatgi A. Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events. J Am Heart Assoc. 2023 Nov 7;12(21):e031160. doi: 10.1161/JAHA.123.031160. Epub 2023 Nov 6. PMID: 37929707; PMCID: PMC10727395.
* Schubert J, Leosdottir M, Lindahl B, Westerbergh J, Melhus H, Modica A, Cater N, Brinck J, Ray KK, Hagström E. Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry. Eur Heart J. 2024 Oct 14;45(39):4204-4215. doi: 10.1093/eurheartj/ehae576. PMID: 39217499; PMCID: PMC11472424.
* Wu D, Lan Y, Ding X, Balmer L, Li X, Wang W, Wu S, Chen Y. Imbalances in circulating monocyte and high-density lipoprotein cholesterol exacerbates the residual risk of incident myocardial infarction beyond LDL-C: a real-life, prospective cohort study. J Transl Med. 2025 Dec 30;23(1):1433. doi: 10.1186/s12967-025-07028-7. Epub 2025 Dec 30. PMID: 41469713; PMCID: PMC12754891.
* Song Y, Chen X, Chang Z, Bian X, He J, Li B, Zheng Z, Wang C, Lin Z, Zhu C, Fu R, Dou K. The cholesterol, high-density lipoprotein, and glucose (CHG) index as a novel metabolic marker for predicting adverse outcomes in myocardial infarction survivors: insights from two large prospective cohorts. Cardiovasc Diabetol. 2026 Feb 24;25(1). doi: 10.1186/s12933-026-03104-4. Epub 2026 Feb 24. PMID: 41731494; PMCID: PMC12980928.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.